Phase 1
๐ Investigational Drug / Biologic
NCT03911388
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
๐ University of Alabama at Birmingham Cancer Center โ Birmingham, Alabama
View Study & Screener โ